Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC

NCT04147728 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Stereotactic Body Radiation Therapy

Interventions

DRUG: Anlotinib
RADIATION: Stereotactic Radiosurgery

Sponsor

Peking University Third Hospital

Collaborators

[object Object]
[object Object]